DiscoverInvesting ExpertsTarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks

Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks

Update: 2024-12-15
Share

Description

Jonathan Faison runs the ROTY Biotech Community. Why he's high on Tarsus Pharmaceuticals and his #1 holding, SpringWorks Therapeutics (0:30 ). Data risk for Ogsiveo and Mirdametinib (5:50 ). This is an excerpt from a recent episode.

Show Notes:
Biotech's Hidden Gems: Smart Strategies For A Challenging Market
SpringWorks Therapeutics Q3 2024 Earnings Call Transcript

Read the transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks

Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks

Seeking Alpha